
Dermatology
Latest News
Latest Videos
More News

A conversation with Gil Yosipovitch, M.D., explores why itch worsens at night, how it rivals chronic pain in quality-of-life impact, and why better assessment of nighttime itch and sleep disruption is urgently needed.

GLP-1 weight-loss drugs can trigger facial fat loss, deepening wrinkles and sagging; experts warn appearance concerns may reduce adherence and affect health outcomes.


Patients using GLP-1 medications may notice facial changes due to fat loss. Vasyukevich stresses education and options for maintaining a youthful appearance.


Research reveals oral probiotics and synbiotics improve atopic dermatitis symptoms, while studies on other skin conditions remain limited.

Combining NB-UVB light therapy with ruxolitinib cream enhances skin repigmentation in vitiligo patients, showing promising results without safety concerns.

A recent study reveals ustekinumab outperforms adalimumab and secukinumab in drug survival for psoriasis, guiding treatment decisions for patients.

New studies from the year revealed connections between medications, environmental factors and innovative treatments for skin conditions including vitiligo and atopic dermatitis.

Winter exacerbates atopic dermatitis in children, but effective management strategies and new treatments offer hope for improved skin health and comfort.

A study reveals that vitiligo significantly impacts quality of life and mental health in Japanese patients, highlighting the need for early psychological support.

A Korean study revealed that stress, not atopic dermatitis itself, significantly impacts sleep quality in adults with the skin condition.

A recent study revealed that patients with hidradenitis suppurativa experience quicker treatment failure when switching to biosimilar adalimumab compared to the original.

Mark Nestor reveals groundbreaking insights on botulinum toxin's evolving science, enhancing its efficacy and expanding its medical applications in dermatology.

Discover how botulinum toxin injections in the glabella affect brain function, enhancing mood by altering emotional feedback from frowning.

AI and virtual care revolutionize dermatology, enhancing melanoma detection, expanding patient access and improving efficiency in clinical practices.

Ruxolitinib cream shows promising results in repigmenting vitiligo lesions, enhancing skin appearance and quality of life with a strong safety profile.

Zoryve cream gains FDA approval for treating mild to moderate atopic dermatitis in young children, offering a safe, steroid-free solution.

A new study confirms ICD-10 code L80's high accuracy in identifying vitiligo, especially when combined with treatment data, enhancing clinical research.

Opzelura gains FDA approval as the first topical JAK inhibitor for children with atopic dermatitis, offering a steroid-free treatment option.

Povorcitinib shows promising results for hidradenitis suppurativa, offering significant lesion reduction and pain relief in recent phase 3 trials.

A recent study revealed that hidradenitis suppurativa affects 1% of the global population, highlighting significant gender disparities and the need for further research.

Discover groundbreaking research on hard-to-treat skin conditions like hidradenitis suppurativa and vitiligo at the EADV 2025 Congress in Paris.

GLP-1 receptor agonists show promise in treating hidradenitis suppurativa, offering significant symptom relief and improved quality of life for patients.

Dupixent shows potential as a treatment for atopic dermatitis, alopecia and vitiligo, targeting shared immune pathways for improved skin health.
































